Statins reduced risk for cancer, mortality in heart transplant recipients

  • May 23, 2012

Patients undergoing heart transplantation who were prescribed statins experienced reductions in the risk for cancer and all-cause mortality, according to data presented at the European Society of Cardiology 2012 Heart Failure Congress.

Further, the beneficial effect of statins on preventing cancer and reducing death from all causes was independent of patients’ cholesterol levels, researchers said.

More »

Additional headlines from ESC Heart Failure Congress 2012

[X]